Kedudukan dalam Saham
#30386
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Harga Saham
$1.25
Disegerakkan terakhir: 2026-08-18
Perubahan (1 hari)
-1.50%
Perubahan (1 tahun)
-22.24%
Perdagangan Aelis Farma S.A. (AELIS)
Harga AELIS dengan permodalan pasaran b
Modal pasaran bagi Aelis Farma S.A.(AELIS)
Modal Pasaran: $17.05M
Sehingga August 2026, Aelis Farma S.A. mempunyai modal pasaran sebanyak $17.05M. Ini menjadikan Aelis Farma S.A. syarikat ke-30386th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Aelis Farma S.A. dari 2022 hingga 2026
AELIS berbanding dengan 5 teratas yang paling popular stocks
| Harga AELIS |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.307T
|
+31,129,810.13%
|
|
|
|
|
$4.551T
|
+26,695,786.97%
|
|
|
|
|
$4.154T
|
+24,370,577.33%
|
|
|
|
|
$3.589T
|
+21,051,335.33%
|
|
|
|
|
$2.797T
|
+16,406,999.17%
|
